Abstract:Introduction Anti-NMDAR encephalitis is an autoimmune disorder, characterized by neuropsychiatric symptoms, such as mood instability, psychosis, catatonia, dyskinesia, seizures and vegetative lability. Psychiatric symptoms usually occur in the initial phase, therefore almost half of the patients are first observed at a psychiatric unit, however in later phases the patients' condition often show progression with the characteristic neurological symptoms, such as perioral dyskinesia and seizures. Although, early recognition and treatment is essential to reach good outcomes, delay in the diagnostic process often happens due to the unspecific early symptoms and the lack of knowledge of this disorder amongst psychiatrists. Moreover, there are cases, where neurological symptoms do not appear, which can lead to diagnostic failure and mismanagement of these patients. Since anti-NMDAR encephalitis is a rare condition, it is important to treat such cases in specific centres, where sufficient knowledge and multidisciplinary approaches are available. Objectives Our aim was to gather all patients' data treated with anti-NMDAR encephalitis at two departments (Neurology and Psychiatry) of Semmelweis University. We wanted to analyse psychiatric manifestations of the disorder in details and follow these symptoms long term, with special interest on the cognitive symptoms. One of our aims was to follow-up these patients and measure antibody titres in their serum, to be able to asses, whether there was any association between prolonged serum positivity and cognitive impairment. Methods We have retrospectively analysed data of previous cases and prospectively followed up recently hospitalised patients. Neurocognitive assessment had been conducted by the same psychologist, all the patients were followed up by the same interdisciplinary team, including a neurologist and two psychiatrists. Laboratory tests (autoimmune antibody essays) were conducted by the Immunological Laboratory at Semmelweis University. Results Altogether, 13 female patients were treated with anti-NMDAR encephalitis in the past ten years at Semmelweis University. All of them received plasma exchange, iv. steroids and azathioprine. 8 out of the 13 needed ventilation and intensive care treatment. 2 of these patients have mild psychiatric symptoms as residual symptoms, and 1 of them is still in the recovery stage, currently experiencing mild cognitive symptoms. Only two patient had ovarian teratomas out of the 13, which is a lower number than expected from previous studies. 4 out of 12 had positive antibody titre at follow up, one patient is still at recovery stage, however her antibody titres are still very high. Conclusions Semmelweis University is one of the largest centre treating patients with anti-NMDAR encephalitis in Hungary. We had altogether 13 patients in the last ten years, with very good outcome, since all of them recovered, although 2 have residual symptoms. Disclosure of Interest None Declared

Agrypnia excitata: a clinical biomarker of acute relapse in anti-NMDAr encephalitis

Cognitive Function Recovery Pattern in Adult Patients with Severe Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Longitudinal Study

Anti-N-Methyl-D-Aspartate Receptor Encephalitis with Occult Ovarian Teratoma: A Case Report

Brain rhythmic abnormalities in convalescent patients with anti-NMDA receptor encephalitis: a resting-state EEG study

Autoimmune Encephalitis and Sleep Disorders

Extreme delta - With or without brushes: A potential surrogate marker of disease activity in anti-NMDA-receptor encephalitis

Reversible dementia and insomnia in ABGA related encephalitis

Abnormal theta-band rhythm: EEG abnormality as potential biomarkers for disease severity in pediatric anti-NMDAR encephalitis

Hypoglutamatergic state is associated with reduced cerebral glucose metabolism in anti-NMDA receptor encephalitis: a case report

Electroencephalogram and Clinical Characteristics and Correlations in Patients With Anti- N -Methyl-d-Aspartate Receptor Encephalitis.

Clinical characteristics and long-term prognosis of relapsing anti-N-methyl-D-aspartate receptor encephalitis: a retrospective, multicenter, self-controlled study

Electroencephalogram and Clinical Characteristics and Correlations in Patients With Anti-<i>N</i>-Methyl-<scp>d</scp>-Aspartate Receptor Encephalitis

Characteristics of clinical relapses and patient-oriented long-term outcomes of patients with anti-N-methyl-D-aspartate receptor encephalitis

Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.

Agrypnia excitata: a human model to explore the derailment of sleep-wake cycle integrated control

Distinctive sleep complaints and polysomnographic findings in antibody subgroups of autoimmune limbic encephalitis

109 Severe dysautonomia in NMDAR encephalitis

Sleep Disturbances Associated with Neurological Autoimmunity

Anti-NMDAR encephalitis alters intrinsic spatiotemporal coding by enhancing neuronal coupling and clustering

Facilitatory/inhibitory intracortical imbalance in REM sleep behavior disorder: early electrophysiological marker of neurodegeneration?

Case-series of patients treated with anti-NMDAR encephalitis at Semmelweis University